Concepedia

Peter Bloomingdale

PB

Statistics

Publications

6

Citations

232

H-Index

6

Active since

2017

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University at Buffalo, State University of New York

Peter Bloomingdale is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacy, and disease modeling.

ORCID

Publications per year

2017–2022

6

Publications

6

Machine Learning in Drug Discovery and Development Part 1: A Primer

Alan Talevi, Juan Francisco Morales, Gregory Hather et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 82 citations · Full text

, , +7

Quantitative systems toxicology

Peter Bloomingdale, Conrad Housand, Joshua F. Apgar et al. · Current Opinion in Toxicology · 2017 · 49 citations · Full text

, , +17

Minimal brain PBPK model to support the preclinical and clinical development of antibody therapeutics for CNS diseases

Peter Bloomingdale, Suruchi Bakshi, Eline van Maanen et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2021 · 37 citations · Full text

, , +17

Machine Learning Models for the Prediction of Chemotherapy-Induced Peripheral Neuropathy

Peter Bloomingdale, Donald E. Mager · Pharmaceutical Research · 2019 · 24 citations

, , +14

PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer’s disease

Peter Bloomingdale, Daniela Bumbaca-Yadav, Jonathan A. Sugam et al. · Frontiers in Pharmacology · 2022 · 23 citations · Full text

, , +17

1–5 of 6